Effects of Empagliflozin on Endogenous Glucose Production in End Stage Renal Disease(ESRD).
NCT03713190
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
25
Enrollment
OTHER
Sponsor class
Conditions
End Stage Renal Disease
Interventions
COMBINATION_PRODUCT:
Empagliflozin
DRUG:
Placebo
Sponsor
University of Pisa